Vasoconstriction by in situ formed angiotensin II: Role of ACE and chymase

Cardiovascular Research

Volumn 44, Issue 2, 1999, Pages 407-415

  MaassenVanDenBrink, Antoinette ^a   De Vries, René ^a   Saxena, Pramod R ^a   Schalekamp, Maarten A D H ^a   Danser, A H Jan ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

ACE inhibitors; Angiotensin; Coronary circulation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN I [5 ISOLEUCINE]; ANGIOTENSIN II [5 ISOLEUCINE]; ANGIOTENSIN RECEPTOR ANTAGONIST; CHYMASE; DIPEPTIDYL CARBOXYPEPTIDASE; IRBESARTAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CHILD; CORONARY ARTERY; CULTURE MEDIUM; DRUG RELEASE; DRUG UPTAKE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; VASOCONSTRICTION;

ADOLESCENT; ADULT; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BIPHENYL COMPOUNDS; CAPTOPRIL; CHILD; CHILD, PRESCHOOL; CHYMASES; CORONARY VESSELS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; PYRIDINES; RECEPTORS, ANGIOTENSIN; SERINE ENDOPEPTIDASES; SWINE; TETRAZOLES; VASOCONSTRICTION;

EID: 0033231827     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00249-7     Document Type: Article

References (30)

1. Ng KKF, Vane JR. Fate of angiotensin I in the circulation. Nature 1968;218:144-150.
2. Admiraal PJJ, Danser AHJ, Jong MS, Pieterman H, Derkx FHM, Schalekamp MADH. Regional angiotensin II production in essential hypertension and renal artery stenosis. Hypertension 1993;21:173-184.
3. Danser AHJ, Koning MM, Admiraal PJJ, Derkx FHM, Verdouw PD, Schalekamp MADH. Metabolism of angiotensin I by different tissues in the intact animal. Am J Physiol 1992;263:H418-428.
4. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-890.
5. Urata H, Strobel F, Ganten D. Widespread tissue distribution of human chymase. J Hypertens 1994;12(Suppl):S17-S22.
6. Urata H, Boehm KD, Philip A et al. Cellular localization and regional distribution of an angiotensin II- forming chymase in the heart. J Clin Invest 1993;91:1269-1281.
7. Wolny A, Clozel J-P, Rein J et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 1997;80:219-227.
8. Balcells E, Meng QC, Johnson Jr. WH, Oparil S, Dell'Italia LJ. Angiotensin II formation from ACE and chymase in human and animal hearts: Methods and species considerations. Am J Physiol 1997;273:H1769-1774.
9. Kokkonen JO, Saarinen J, Kovanen PT. Regulation of local angiotensin II formation in the human heart in the presence of interstitial fluid. Inhibition of chymase by protease inhibitors of interstitial fluid and of angiotensin-converting enzyme by Ang-(l-9) formed by heart carboxypeptidase A-like activity. Circulation 1997;95:1455-1463.
10. Zisman LS, Abraham WT, Meixell GE et al. Angiotensin II formation in the intact human heart. Predominance of the angioten-sin-converting enzyme pathway. J Clin Invest 1995;96:1490-1498.
11. 125I] labelled angiotensin I in isolated perfused porcine coronary and carotid arteries. Cardiovasc Res 1995;29:789-795.
12. Cockroft JR, Keogh BE, Webb DJ, Ritter JM, Taylor KM. Responses to angiotensin with and without angiotensin-converting enzyme inhibition in the canine left anterior descending coronary artery. Am J Cardiol 1993;71:1498-1499.
13. van Kats JP, Sassen LMA, Danser AHJ et al. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renm inhibitor remikiren. Br J Pharmacol 1996;117:891-901.
14. 1B/1D and novel receptors. Br J Pharmacol 1998;123:1561-1570.
15. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998;98:25-30.
16. de Lannoy LM, Danser AHJ, Bouhuizen AMB, Saxena PR, Schalekamp MADH. Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension 1998;31:1111-1117.
17. Admiraal PJJ, Derkx FHM, Danser AHJ, Pieterman H, Schalekamp MADH. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 1990;15:44-55.
18. de Lean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 1978;235:E97-E102.
19. Yang Z, Richard V, von Segesser L et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Circulation 1990;82:188-195.
20. Borland JAA, Chester AH, Morrison KA, Yacoub MH. Alternative pathways of angiotensin II production in the human saphenous vein. Br J Pharmacol 1998;125:423-428.
21. Voors AA, Pinto YM, Buikema H et al. Dual pathways for angiotensin II formation in human internal mammary arteries. Br J Pharmacol 1998;125:1028-1032.
22. Ackermann A, Ferńndez-Alfonso MS, Śnchez de Rojas R, Ortega T, Paul M, González C. Modulation of angiotensin-converting enzyme by nitric oxide. Br J Pharmacol 1998; 124:291 298.
23. Itazaki K, Shigeri Y, Fujimoto M. Molecular cloning and characterization of the angiotensin receptor subtype in porcine aortic smooth muscle. Eur J Pharmacol 1993;245:147-156.
24. Regitz-Zagrosek V, Friedel N, Heymann A et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91:1461-1471.
25. Nozawa Y, Haruno A, Oda N et al. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J Pharmacol Exp Ther 1994;270:566-571.
26. Patel JM, Sekharam KM, Block ER. Angiotensin receptor-mediated stimulation of diacylglycerol production in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 1991;5:321-327.
27. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998;32:514-520.
28. Takai S, Shiota N, Jin D, Miyazaki M. Functional role of chymase in angiotensin II formation in human vascular tissue. J Cardiovasc Pharmacol 1998;32:826-833.
29. Hilgers KF, Bingener E, Stumpf C, Müller DN, Schmieder RE, Veelken R. Angiotensinases restrict locally generated angiotensin II to the blood vessel wall. Hypertension 1998;31:368-372.
30. Nussberger J, Brunner DB, Waeber B, Brunner HR. Specific measurement of angiotensin metabolites and in vitro generation of angiotensin II in plasma. Hypertension 1986;8:476-482.